The short version
8 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Foscarnet Sodium
Foscarnet Sodium · FOSCARNET SODIUM 24 mg/mL · Injection, Solution · Intravenous · Gland Pharma Limited
NDC 68083-0389-01 · 1 BAG in 1 CARTON / 250 mL in 1 BAG · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Gland Pharma LimitedIndiaanalysis · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $2,174.86 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA213001
- TE code
- AP
- Approval date
- Apr 21, 2021
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Foscarnet Sodium (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Baxter Healthcare Corporation | FOSCARNET SODIUM 6000 mg/250mL | Jul 15, 2026 | Sep 2, 2026 |
| Caplin Steriles Limited | FOSCARNET SODIUM 24 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | FOSCARNET SODIUM 24 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | FOSCARNET SODIUM 24 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | FOSCARNET SODIUM 24 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | FOSCARNET SODIUM 24 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | FOSCARNET SODIUM 24 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Clinigen Limited | FOSCARNET SODIUM 24 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Foscarnet Sodium — NDC 68083-0389-01," retrieved September 3, 2026, https://drugdashboards.com/drug/68083038901.
Free to cite with attribution — see how the data is put together.